BioCentury
ARTICLE | Company News

Genzyme sales and marketing update

July 26, 2010 7:00 AM UTC

Genzyme said that as of July 21, it had enrolled 122 late-onset Pompe's disease patients in its Alglucosidase Alfa Control and Education (ACE) program, most of whom had previously been enrolled in its...